Issue
Title
Authors
No 10 (2018)
Regulatory aspects of the introduction of the drug therapy outcomes-based payment concept
Tolkushin A.G., Fedorov A.A., Yagudina R.I., Davydovskaya M.V., Chernitskaya M.K., Ermolaeva T.N., Kobzeva N.V., Kokushkin K.A.
PDF
(Rus)
No 11 (2019)
EAEU registration procedure: opportunities for work automation
Olefir Y.V., Rychikhina E.M., Koshechkin K.A.
PDF
(Rus)
No 10 (2020)
Innovative medicines on the Russian pharmaceutical market:key players and main directions of development
Chaplenko A.A., Vlasov V.V., Gildeeva G.N.
PDF
(Rus)
No 10 (2019)
Experiment ahead of time: about the Moscow experiment on preferential drug provision
Telnova E.A.
PDF
(Rus)
No 4 (2021)
Development of proposals for improving the processes of circulation of extemporal drugs and regulation of prescription and production activities of pharmaceutical organizations in the Russian Federation
Narkevich I.A., Golant Z.M., Yurochkin D.S., Leshkevich A.A., Erdni-Garyaev S.E.
No 10 (2018)
The importance of pharmaceutical quality system design at the drug manufacturers in the context of formation of the EAEU pharmaceutical market
Goryachkin V.V., Smirnov V.A., Shestakov V.N., Abramovich R.A., Denisova M.N.
PDF
(Rus)
No 4 (2019)
CHALLENGES AND ISSUES IN OPERATING PERSONNEL MANAGEMENT DURING THE IMPLEMENTATION OF PHARMACEUTICAL QUALITY SYSTEM
SMIRNOV V.A., GORYACHKIN V.V., SHESTAKOV V.N., ABRAMOVICH R.A.
PDF
(Rus)
No 3 (2022)
Analysis of the budget expenditure for rare diseases in the subjects of the Russian Federation
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 4 (2019)
Non-adherence as the reason for unreliable result s of a clinical study
MELIKHOV O.G., TATARENKO A.O.
PDF
(Rus)
No 2 (2022)
Peoples preferential provision of medicines, medical devices, specialized health food products: system and regulation in the Perm region
Maleeva T.L., Shilnikova S.V., Novikova N.V., Tarasevich V.N.
PDF
(Rus)
No 6 (2018)
State policy in the sphere of pharmaceutics in the USSR in the 1930s
Sherstneva E.V.
PDF
(Rus)
No 4 (2019)
PRESCRIPTION DRUG INSURANCE: CHOOSING A PATH
Popovich L.D.
PDF
(Rus)
No 2 (2022)
The use of the Min-Max method in assessing the effectiveness of health care and drug provision of the population
Yagudina R.I., Gavrilina N.I.
PDF
(Rus)
No 6 (2018)
How much does humanity weigh?
Philippova I.
PDF
(Rus)
No 3 (2019)
Review of Federal medicine assistance schemes
Kovaleva K.A., Narkevich I.A., Nemyatykh D., Vasyagina Y.A.
PDF
(Rus)
No 2 (2022)
“New” rare diseases and budget deficiency: is the problem “great”?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 1-2 (2018)
State regulation of prices on medicines: search for balance
Kopytin D.A.
PDF
(Rus)
No 3 (2019)
Review of PIC/S guidance on classification of GMP deficiencies
Orlov V.A.
PDF
(Rus)
No 2 (2022)
Improving operational pharmacovigilance systems in the context of new geopolitical risks
Krasheninnikov A.E.
PDF
(Rus)
No 12 (2019)
International approaches to the formation of the quality system of the pharmaceutical inspectorate
Nikolenko N.S., Beregovykh V.V.
PDF
(Rus)
No 11-12 (2020)
Analysis of performance indicators of the High-cost Nosologies program in the constituent entities of the Russian Federation
Petrukhina I.K., Yagudina R.I., Ryazanova T.K., Gladunova E.P., Egorova A.V., Khusainova A.I., Blinkova P.R., Loginova L.V.
PDF
(Rus)
No 1 (2022)
Activities of municipalities in the field of drug provision of the population in Russia in the second half of the XIX - early XX century
Sherstneva E.V., Egorysheva I.V.
No 1 (2022)
Rare diseases in the subjects of the Russian Federation: are these patients rare?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
No 9 (2020)
3D printing in pharmacy
Prozherina Y.
PDF
(Rus)
No 4 (2021)
Organization of work of the staff of a pharmacy organization in the pharmacovigilance system
Kurganova E.Y., Soloninina A.V., Poskrebysheva A.S.
No 9 (2019)
Development of the rare (orphan) drug market
Yurochkin D.S., Golant Z.M., Narkevich I.A.
PDF
(Rus)
No 4-6 (2020)
Overview of key launches on the Russian pharmaceutical market, 2019
Kalinina N.
PDF
(Rus)
No 7-8 (2019)
Analysis of the drug assortment for palliative care for children in the Russian Federation
Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Vrubel E.T.
PDF
(Rus)
No 1-3 (2020)
Drug product release in 2019
Romanova S.
PDF
(Rus)
No 13S (2018)
Vikram Punia: «Our key goal is to reduce dependence of the country on drug imports»
Article E.
PDF
(Rus)
No 5 (2019)
Nomenclature of gene-therapy drugs: international experience
Mokhov A.A., Merkulov V.A., Melnikova E.V., Popov P.I., Dudchenko V.V., Koshechkin К.А., Chaplenko A.A., Yavorsky A.N.
PDF
(Rus)
No 1-3 (2020)
Russian Pharmaceutical Market in 2019
Kalinina N.
PDF
(Rus)
1 - 32 of 32 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies